Replication of the genetic effects of IFN regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population
- PMID: 17389033
- PMCID: PMC1906810
- DOI: 10.1186/ar2152
Replication of the genetic effects of IFN regulatory factor 5 (IRF5) on systemic lupus erythematosus in a Korean population
Abstract
Recently, two studies provided convincing evidence that IFN regulatory factor 5 (IRF5) gene polymorphisms are significantly associated with systemic lupus erythematosus (SLE) in several white populations. To replicate the association with SLE in an Asian population, we examined the genetic effects in our SLE cohort from a Korean population. A total of 1,565 subjects, composed of 593 cases and 972 controls, were genotyped using the TaqMan (Applied Biosystems, Foster City, CA, USA) method. The genetic effects of polymorphisms on the risk of SLE were evaluated using chi2 tests and a Mantel-Haenszel meta-analysis. Statistical analysis revealed results in the Korean population were similar to the previous reports from white populations. The rs2004640 T allele had a higher frequency in SLE cases (0.385) than controls (0.321; odds ratio (OR) = 1.32, P = 0.0003). In combined analysis, including all seven independent cohorts from the three studies so far, robust and consistent associations of the rs2004640 T allele with SLE were observed. The estimate of risk was OR = 1.44 (range, 1.34-1.55), with an overall P = 1.85 x 10(-23) for the rs2004640 T allele. The haplotype (rs2004640T-rs2280714T) involved in both the alternative splice donor site and the elevated expression of IRF5 also had a highly significant association with SLE (pooled, P = 2.11 x 10(-16)). Our results indicate that the genetic effect on the risk of SLE mediated by IRF5 variants can be generally accepted in both white and Asian populations.
Similar articles
-
Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms.Arthritis Rheum. 2008 Mar;58(3):826-34. doi: 10.1002/art.23216. Arthritis Rheum. 2008. PMID: 18311811
-
Different genetic effects of interferon regulatory factor 5 (IRF5) polymorphisms on systemic lupus erythematosus in a Korean population.J Rheumatol. 2008 Nov;35(11):2148-51. doi: 10.3899/jrheum.080124. Epub 2008 Oct 1. J Rheumatol. 2008. PMID: 18843782
-
Association between the rs2004640 functional polymorphism of interferon regulatory factor 5 and systemic lupus erythematosus: a meta-analysis.Rheumatol Int. 2009 Aug;29(10):1137-42. doi: 10.1007/s00296-008-0801-7. Epub 2008 Nov 29. Rheumatol Int. 2009. PMID: 19043711
-
Association of IRF5 rs2004640 polymorphism and systemic lupus erythematosus: A meta-analysis.Int J Rheum Dis. 2019 Sep;22(9):1598-1606. doi: 10.1111/1756-185X.13654. Epub 2019 Jul 25. Int J Rheum Dis. 2019. PMID: 31347288
-
Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients.Clin Rheumatol. 2024 Aug;43(8):2403-2416. doi: 10.1007/s10067-024-07046-8. Epub 2024 Jul 4. Clin Rheumatol. 2024. PMID: 38963465 Review.
Cited by
-
Analysis of East Asia genetic substructure using genome-wide SNP arrays.PLoS One. 2008;3(12):e3862. doi: 10.1371/journal.pone.0003862. Epub 2008 Dec 5. PLoS One. 2008. PMID: 19057645 Free PMC article.
-
Association of STAT4 polymorphism with severe renal insufficiency in lupus nephritis.PLoS One. 2013 Dec 27;8(12):e84450. doi: 10.1371/journal.pone.0084450. eCollection 2013. PLoS One. 2013. PMID: 24386384 Free PMC article. Clinical Trial.
-
Recent advances in the genetics of autoimmune disease.Annu Rev Immunol. 2009;27:363-91. doi: 10.1146/annurev.immunol.021908.132653. Annu Rev Immunol. 2009. PMID: 19302045 Free PMC article. Review.
-
The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share.Hum Mol Genet. 2015 Jan 15;24(2):582-96. doi: 10.1093/hmg/ddu455. Epub 2014 Sep 8. Hum Mol Genet. 2015. PMID: 25205108 Free PMC article.
-
RNA-Seq for enrichment and analysis of IRF5 transcript expression in SLE.PLoS One. 2013;8(1):e54487. doi: 10.1371/journal.pone.0054487. Epub 2013 Jan 18. PLoS One. 2013. PMID: 23349905 Free PMC article.
References
-
- Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, Ortmann WA, Koeuth T, Gonzalez Escribano MF, Pons-Estel B, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet. 2006;38:550–555. doi: 10.1038/ng1782. - DOI - PubMed
-
- Sigurdsson S, Nordmark G, Goring HH, Lindroos K, Wiman AC, Sturfelt G, Jonsen A, Rantapaa-Dahlqvist S, Moller B, Kere J, et al. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet. 2005;76:528–537. doi: 10.1086/428480. - DOI - PMC - PubMed
-
- Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39:363–369. doi: 10.1002/art.1780390303. - DOI - PubMed
-
- Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. Genet Anal. 1999;14:143–149. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical